Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Robenidine is a synthetic coccidiostat and antibiotic primarily used in veterinary medicine to prevent and treat coccidiosis, a protozoal infection caused by various *Eimeria* species in poultry (broiler chickens, turkeys) and rabbits. It functions by interfering with the energy metabolism of coccidian parasites, disrupting mitochondrial function, and decreasing adenosine triphosphate (ATP) production, which is crucial for parasite survival and reproduction. Robenidine exhibits both coccidiostatic activity, by arresting the development of first-generation schizonts, and coccidiocidal effects, by directly killing second-generation schizonts and merozoites, thereby disrupting both asexual and sexual stages of the parasite's life cycle. It is typically administered orally as a medicated feed additive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Robenidine.